Toll-like receptors as potential therapeutic targets for multiple diseases
- 1 October 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 1 (10) , 797-807
- https://doi.org/10.1038/nrd914
Abstract
The family of Toll-like receptors (TLRs) is receiving considerable attention as potential regulators and controllers of the immune response through their ability to recognize pathogen-associated molecular patterns. The discovery that endogenous ligands, as well as microbial components, are recognized by TLRs, and that small-molecular-mass synthetic compounds activate TLRs, raised interest in these receptors as potential targets for the development of new therapies for multiple diseases. In this review, we discuss the current and future use of TLR agonists or antagonists in chronic inflammatory diseases and highlight potential problems that are associated with such approaches.Keywords
This publication has 112 references indexed in Scilit:
- The immune system evolved to discriminate infectious nonself from noninfectious selfPublished by Elsevier ,2003
- Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848Nature Immunology, 2002
- Modulation of the expression of cyclooxygenase‐2 by fatty acids mediated through Toll‐like receptor 4‐derived signaling pathways1The FASEB Journal, 2001
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe diseaseJournal of Allergy and Clinical Immunology, 2001
- Lipopolysaccharide augments IgG and IgE responses of mice to the latex allergen Hev b 5Journal of Allergy and Clinical Immunology, 1998
- Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway EosinophiliaThe Journal of Experimental Medicine, 1998
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healingJournal of Theoretical Biology, 1986